
The Wall Street Journal @WSJ
Federal regulators approved a drug to treat a debilitating disease using data collected about patients over decades, creating an opening for researchers of other rare conditions who often struggle to prove their treatments work https://t.co/WBYpwV7Zqx — PolitiTweet.org